---
title: "Guanze Medical Information Industry (Holding) Co., Ltd. (02427.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02427.HK.md"
symbol: "02427.HK"
name: "Guanze Medical Information Industry (Holding) Co., Ltd."
industry: "医疗产品分销商"
---

# Guanze Medical Information Industry (Holding) Co., Ltd. (02427.HK)

| Item | Detail |
|------|--------|
| Industry | 医疗产品分销商 |
| Location | 港股市场 |
| Website | [www.guanzegroup.com](https://www.guanzegroup.com) |

## Company Profile

Guanze Medical Information Industry (Holding) Co Ltd 是一家主要从事医用影像胶片产品销售以及提供医学影像云服务的投资控股公司。该公司及其子公司从事向医院及医疗机构销售购自国际品牌的医用影像胶片以及自有 “冠泽慧医” 品牌的医用影像胶片。该公司分销或提供的医用影像胶片类型主要包括医用干式激光胶片、热敏胶片及医用打印胶片。该公司的医学影像云服务主要包括数字医学影像云存储平台、数字医学影像平台、区域影像诊断平台以及 PACS 系统。该公司主要在中国国内市场开展业务。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-19T04:30:13.000Z

**Overall: B (0.28)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 2 / 21 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 21.45% |  |
| Net Profit YoY | 81.20% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 9.84 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2.84B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 160.01M |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 8.22% | B |
| Profit Margin | 14.05% | B |
| Gross Margin | 42.01% | B |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 21.45% | A |
| Net Profit YoY | 81.20% | A |
| Total Assets YoY | 12.29% | B |
| Net Assets YoY | 11.29% | B |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 711.77% | B |
| OCF YoY | 21.45% | A |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.51 | C |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 13.28% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Guanze Medical Information Industry (Holding) Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "8.22%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "14.05%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "42.01%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "21.45%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "81.20%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.29%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "11.29%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "711.77%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "21.45%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.51",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "13.28%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 药师帮 (HK.9885) | C | B | A | D | B | B |
| 02 | GUANZE MEDICAL (HK.2427) | B | A | C | A | B | B |
| 03 | 君百延集团 (HK.8372) | B | B | B | A | B | B |
| 04 | 上海医药 (HK.2607) | C | C | A | D | B | C |
| 05 | 白云山 (HK.874) | C | C | A | C | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 124.95 | 12/23 | 25.73 | 22.15 | 16.87 |
| PB | 9.84 | 18/23 | 1.91 | 1.58 | 1.12 |
| PS (TTM) | 17.55 | 21/23 | 3.41 | 2.76 | 1.86 |
| Dividend Yield | 0.00% | - | 6.77% | 6.46% | 6.18% |

## References

- [Company Overview](https://longbridge.com/en/quote/02427.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02427.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02427.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.